Prevention and treatment of no-reflow

References

• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet. 2003;361:13–20.
   PubMed Web of Science ®Google Scholar
• Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656–62.
   PubMed Web of Science ®Google Scholar
• Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanims and therapies. Eur Heart J. 2001;22:729–39.
   PubMed Web of Science ®Google Scholar
• Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation. 1993;88:1361–74.
   PubMed Web of Science ®Google Scholar
• Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, . Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107:2115–19.
   PubMed Web of Science ®Google Scholar
• Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909–13.
   PubMed Web of Science ®Google Scholar
• McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, . Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction. The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol. 2004;44:1215–23.
   PubMed Web of Science ®Google Scholar
• Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, . Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004, 109:1121–26.
   PubMed Web of Science ®Google Scholar
• Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F, La Torre G, . AMICI investigators. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: Results of the multicenter AMICI study. J Am Coll Cardiol. 2008;51:552–9.
   PubMed Web of Science ®Google Scholar
• Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, . Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–72.
   PubMed Web of Science ®Google Scholar
• Iliceto S, Marangelli V, Marchese A, Amico A, Galiuto L, Rizzon P. Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications. Eur Heart J. 1996;17:344–53.
   PubMed Web of Science ®Google Scholar
• Hayat SA, Senior R. Myocardial contrast echocardiography in ST elevation myocardial infarction: Ready for prime time? Eur Heart J. 2008;29:299314.
   PubMed Web of Science ®Google Scholar
• Albert TS, Kim RJ, Judd RM. Assessment of no-reflow regions using cardiac MRI. Basic Res Cardiol. 2006;101:383–90.
   PubMed Web of Science ®Google Scholar
• Pollack C Jr. Pharmacological and mechanical revascularization strategies in STEMI: integration of two approaches. J Invasive Cardiol. 2008;20:231–8.
   PubMed Web of Science ®Google Scholar
• Hassan AK, Liem SS, van der Kley F, Bergheanu SC, Wolterbeek R, Bosch J, . In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure. Results from the Leiden MISSION! acute myocardial infarction treatment optimization program. Catheter Cardiovasc Interv. 2009;74:335–43.
   PubMed Web of Science ®Google Scholar
• Rezkalla SH, Kloner RA. Ischemic preconditioning and preinfarction angina in the clinical arena. Nat Clin Pract Cardiovasc Med. 2004;1:96–102.
   PubMedGoogle Scholar
• Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, . Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: The randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation. 2008;118:49–57.
   PubMed Web of Science ®Google Scholar
• Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med. 2007;357:1631–8.
   PubMed Web of Science ®Google Scholar
• Montalescot G, Ongen Z, Guindy R, Sousa A, Lu SZ, Pahlajani D, . for the RIVIERA Investigators. Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study. Int J Cardiol. 2008;129:379–87.
   PubMed Web of Science ®Google Scholar
• Collet JP, Montalescot G. The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes. Diabetes Vasc Dis Res. 2005;2:136–43.
   PubMedGoogle Scholar
• Golino P, Maroko PR, Carew TE. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. Circulation. 1987;75:292–8.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Hiasa Y, Ohara Y, Miyazaki S, Ogura R, Miyajima H, . Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. Am J Cardiol. 2007;100:35–40.
   PubMed Web of Science ®Google Scholar
• Campo G, Valgimigli M, Gemmati D, Percoco G, Tognazzo S, Cicchitelli G, . Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention. Insights into the STRATEGY Study. J Am Coll Cardiol. 2006;48:2178–85.
   PubMed Web of Science ®Google Scholar
• Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, . Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005;46:284–90.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, . Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J. 2008;29:1843–50.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Lanza GA, Shaw S, Romagnoli E, Gioia D, Burzotta F, . Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization. Eur Heart J. 2006;27:1793–8.
   PubMed Web of Science ®Google Scholar
• Bagchi D, Wetscher GJ, Bagchi M, Hinder PR, Perdikis G, Stohs SJ, . Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury. Chem Biol Interact. 1997;104:65–85.
   PubMed Web of Science ®Google Scholar
• Forde RC, Fitzgerald DJ. Reactive oxygen species and platelet activation in reperfusion injury. Circulation. 1997;95:787–9.
   PubMed Web of Science ®Google Scholar
• Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol. 1996;28(Suppl. 1):S1–10.
   PubMed Web of Science ®Google Scholar
• Kaneko M, Matsumoto Y, Hayashi H, Kobayashi A, Yamazaki N. Oxygen free radicals and calcium homeostasis in the heart. Mol Cell Biochem. 1994;139:91–100.
   PubMed Web of Science ®Google Scholar
• Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101:2154–9.
   PubMed Web of Science ®Google Scholar
• Claeys MJ, Bosmans J, De Ceuninck M, Beunis A, Vergauwen W, Vorlat A, . Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol. 2004;94:9–13.
   PubMed Web of Science ®Google Scholar
• Quintana M, Hjemdahl P, Sollevi A, Kahan T, Edner M, Rehnqvist N, . Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the attenuation by adenosine of cardiac complications (ATTACC) study. Eur J Clin Pharmacol. 2003; 59:1–9.
   PubMed Web of Science ®Google Scholar
• Amit G, Cafri C, Yaroslavtsev SFuchs S, Paltiel O, Abu-Ful A, . Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 2006;152:887.e9–14.
   PubMed Web of Science ®Google Scholar
• Shinozaki N, Ichinose H, Yahikozawa K, Shimada H, Hoshino K. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction. Int Heart J. 2007;48:423–33.
   PubMed Web of Science ®Google Scholar
• Lipsic E, Schoemaker RG, van der Meer P, Voors AA, van Veldhuisen DJ, van Gilst WH. Protective effects of erythropoietin in cardiac ischemia. J Am Coll Cardiol. 2006;48: 2161–7.
   PubMed Web of Science ®Google Scholar
• Lipsic E, van der Meer P, Voors AA, Westenbrink BD, van den Heuvel AF, de Boer HC, . A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study. Cardiovasc Drugs Ther. 2006;20:135–41.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Inoue N, Takaoka H, Hata K, Shinke T, Yoshikawa R, . Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction. Clin Cardiol. 2004;27:466–70.
   PubMed Web of Science ®Google Scholar
• Booth EA, Lucchesi BR. Estrogen-mediated protection in myocardial ischemia-reperfusion injury. Cardiovasc Toxicol. 2008;8:101–13.
   PubMed Web of Science ®Google Scholar
• Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, . Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473–81.
   PubMed Web of Science ®Google Scholar
• Baxter GF. Natriuretic peptides and myocardial ischaemia. Basic Res Cardiol. 2004;99:90–3.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Tsutsui T, . Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol. 2001;37:1820–6.
   PubMed Web of Science ®Google Scholar
• Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, . Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1–7.
   PubMed Web of Science ®Google Scholar
• Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, . Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:56–65.
   Web of Science ®Google Scholar
• Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, Date M, . Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27:534–9.
   PubMed Web of Science ®Google Scholar
• Karila-Cohen D, Czitrom D, Brochet E, Faraggi M, Seknadji P, Himbert D, . Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina. Eur Heart J. 1999;20:1724–30.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Altamura L, Fabretti A, Lanza AG, Biasucci LM, Rebuzzi AG, . Ethanol abolishes ischemic preconditioning in humans. J Am Coll Cardiol. 2008;51:271–5.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, . Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: A randomised controlled trial. Lancet. 2007;370:575–9.
   PubMed Web of Science ®Google Scholar
• Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A, . Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation. 1994;90:700–5.
   PubMed Web of Science ®Google Scholar
• Van der Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, . Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J. 2008;29:2909–45.
   PubMed Web of Science ®Google Scholar
• Stone JW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, . Distal microcirculatory protection during percutaneous coronary intervention in acute ST elevation myocardial infarction. JAMA 2005;239:1063–72.
   Google Scholar
• Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, . Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation. 2005;112:1462–9.
   PubMed Web of Science ®Google Scholar
• Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, . Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol. 2006;48:244–52.
   PubMed Web of Science ®Google Scholar
• Burzotta F, Testa L, Giannico F, Biondi-Zoccai GG, Trani C, Romagnoli E, . Adjunctive devices in primary or rescue PCI: A meta-analysis of randomized trials. Int J Cardiol. 2008;123:313–21.
   PubMed Web of Science ®Google Scholar
• Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: A comprehensive meta-analysis of randomized trials. Eur Heart J. 2008;29:2989–3001.
   PubMed Web of Science ®Google Scholar
• Burzotta F, Trani C, Romagnoli E, Mazzari MA, Rebuzzi AG, De Vita M, . Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol. 2005;46:371–6.
   PubMed Web of Science ®Google Scholar
• Galiuto L, Garramone B, Burzotta F, Lombardo A, Barchetta S, Rebuzzi AG, . REMEDIA investigators. Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: A myocardial contrast echocardiography substudy of the REMEDIA trial. J Am Coll Cardiol. 2006;48:1355–60.
   PubMed Web of Science ®Google Scholar
• Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, . Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008;358:557–67.
   PubMed Web of Science ®Google Scholar
• De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A meta-analysis of randomized trials. Eur Heart J. 2008;29:3002–10.
   PubMed Web of Science ®Google Scholar
• Stoel MG, Marques KM, de Cock CC, Bronzwaer JG, von Birgelen C, Zijlstra F. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv. 2008;71:283–9.
   PubMed Web of Science ®Google Scholar
• Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, . Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The acute myocardial infarction study of adenosine (AMISTAD) trial. JACC Vol. 34, No. 6, 1999. J Am Coll Cardiol. 1999;34:1711–20.
   PubMed Web of Science ®Google Scholar
• Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. AMISTAD-II investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005;45:1775–80.
   PubMed Web of Science ®Google Scholar
• Micari A, Belcick TA, Balcells EA, Powers E, Wei K, Kaul S, . Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. Am J Cardiol. 2005;96:1410–5.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Lo PH, Lin JJ, Lee H, Hung JS. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv. 2004;63:171–6.
   PubMed Web of Science ®Google Scholar
• Pasceri V, Pristipino C, Pelliccia F, Granatelli A, Speciale G, Roncella A, . Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol. 2005;95:1358–61.
   PubMed Web of Science ®Google Scholar
• Airoldi F, Briguori C, Cianflone D, Cosgrave J, Stankovic G, Godino C, . Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside. Am J Cardiol. 2007;99:916–20.
   PubMed Web of Science ®Google Scholar
• Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, . Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomized trials. Lancet. 2007;370:1483–93.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Minatoguchi S, Uno Y, Kariya T, Arai M, Yamashita K, . Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits. Int J Cardiol. 1997;62:181–90.
   PubMed Web of Science ®Google Scholar
• Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, . Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654–60.
   PubMed Web of Science ®Google Scholar
• Ono H, Osanai T, Ishizaka H, Hanada H, Kamada T, Onodera H, . Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Role of inhibitory effect on reactive oxygen species formation. Am Heart J. 2004;148:E15.
   PubMed Web of Science ®Google Scholar
• Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, . Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997;30:1193–9.
   PubMed Web of Science ®Google Scholar
• Werner GS, Lang K, Kuehnert H, Figulla HR. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv. 2002;57:444–51.
   PubMed Web of Science ®Google Scholar
• Cameron AJV, Hutton L, Kenmure ACF, Murdoch WR. Haemodynamic and metabolic effects of hyperbaric oxygen in myocardial infarction. Lancet. 1966;2:833–7.
   PubMed Web of Science ®Google Scholar
• Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, . Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation. 1993;88:1931–6.
   PubMed Web of Science ®Google Scholar
• Thomas MP, Brown LA, Sponseller DR, Williamson SE, Diaz JA, Guyton DP. Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator. Am Heart J. 1990;120:791–800.
   PubMed Web of Science ®Google Scholar
• Glazier JJ. Attenuation of reperfusion microvascular ischemia by aqueous oxygen: Experimental and clinical observations. Am Heart J. 2005;149:580–4.
   PubMed Web of Science ®Google Scholar
• Trabattoni D, Bartorelli AL, Fabbiocchi F, Montorsi P, Ravagnani P, Pepi M, . Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2006;67:859–65.
   PubMed Web of Science ®Google Scholar
• O'Neill WW, Martin JL, Dixon SR, Bartorelli AL, Trabattoni D, Oemrawsingh PV, . Acute myocardial infarction with hyperoxemic therapy (AMIHOT): A prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50:397–405.
   PubMed Web of Science ®Google Scholar
• Dixon SR, Bartorelli AL, Marcovitz PA, Spears R, David S, Grinberg I, . Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction. Results of a pilot study utilizing intracoronary aqueous oxygen therapy. J Am Coll Cardiol. 2002;39:387–92.
   PubMed Web of Science ®Google Scholar
• Maekawa K, Kawamoto K, Fuke S, Yoshioka R, Saito H, Sato T, . Effects of intraaortic balloon pumping on the angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with anterior myocardial infarction. Circ J. 2006;70:37–43.
   PubMed Web of Science ®Google Scholar
• Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, . A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J. 2009;30:459–68.
   PubMed Web of Science ®Google Scholar
• Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, . Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–88.
   PubMed Web of Science ®Google Scholar
• Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, . Postconditioning the human heart. Circulation. 2005;112:2143–8.
   PubMed Web of Science ®Google Scholar
• Galiuto L, Lombardo A, Maseri A, Santoro L, Porto I, Cianflone D, . Temporal evolution and functional outcome of no reflow: Sustained and spontaneously reversible patterns following successful coronary recanalization. Heart. 2003;89:731–7.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Haager R, Arning J, Christott P, Radke P, Blindt R, . Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function. Am J Cardiol. 2003;92:1015–9.
   PubMed Web of Science ®Google Scholar
• Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, . Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. J Interv Cardiol. 2005;18:261–6.
   PubMedGoogle Scholar
• Antoniucci D, Valenti R, Migliorini A, Parodi G, Memisha G, Santoro GM, . Comparison of rheolytic thrombectomy before direct infarct artery stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2004;93:1033–5.
   PubMed Web of Science ®Google Scholar
• Beran G, Lang I, Shreiber W, Denk S, Stefenelli T, Syeda B, . Intracoronary thrombectomy with the X-Sizer catheter system improve epicardial flow and accelerates ST segment resolution in patients with acute coronary syndrome. Circulation. 2002;105:2355–60.
   PubMed Web of Science ®Google Scholar
• Napodano M, Pasquetto G, Saccà S, Cernetti C, Scarabeo V, Pascotto P, . Intracoronary thrombectomy improve myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003;42:1395–402.
   PubMed Web of Science ®Google Scholar
• Lefevre T, Garcia E, Reimers B, Lang I, di Mario C, Colombo A, . X-Sizer for thrombectomy in acute myocardial infarction improves ST segment resolution (X AMINE ST). J Am Coll Cardiol. 2005;46:246–52.
   PubMed Web of Science ®Google Scholar
• Fujita N, Suwa S, Koyama S, Saito M, Muramatsu T, for the ASPARAGUS investigators. The efficacy of distal embolic protection device during an acute myocardial infarction: early and long term results. Am J Cardiol. 2004;94(Suppl. 6A):34E.
   Google Scholar
• Limbruno U, Micheli A, de Carlo M, Amoroso G, Rossini R, Palagi C, . Mechanical prevention of distal embolization during primary angioplasty. Circulation. 2003;108:171–6
   PubMed Web of Science ®Google Scholar
• Morice M. Filters in AMI may work where balloon occlusion/aspiration systems don't. Available at http://www.tctmd.com. Accessed 27 October 2004.
   Google Scholar
• Bonios MJ, Pierrakos CN, Argiriou M, Dalianis A, Terrovitis JV, Dolou P, . Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion Int J Cardiol. 2010;138:253–60.
   Web of Science ®Google Scholar